GeneNews Diagnostics Launches ColonSentry in Malaysia
GeneNews Limited has announced the commercial launch of ColonSentry™, the world's first blood-based test to determine a person's current risk for colorectal cancer, in Malaysia through GeneNews Diagnostics Sdn. Bhd.
The formal launch ceremony was officiated by Y'B Senator Tan Sri Dr. Koh Tsu Koon, a Minister in the Malaysian Prime Minister's Department.
"We are excited that GeneNews Diagnostics will now be able to provide the Malaysian population with access to this potentially life-saving colorectal cancer pre-screening tool. We also believe that commercial success in Malaysia, a key country in the Southeast Asian market, will help facilitate the commercial expansion of the ColonSentry test throughout this part of the world", said Gailina J. Liew, President and Chief Operating Officer of GeneNews.